Abstract
Because methylxanthines modulate apnea and enhance intercostal and diaphragmatic contractility, we hypothesized that administration of theophylline to infants < 1250 gm on low ventilatory settings would facilitate extubation and prevent post-extubation respiratory failure. A prospective, randomized, blinded, placebo-controlled trial was performed. Twenty-five infants [11 placebo (P), 14 treated (T)] who were < 1250 grams on assisted ventilation with FiO2 ≤ .30, PIP ≤ 20, IMV ≤ 10 were enrolled. Electrolyte abnormalities and anemia were corrected before entry and absence or stability of IVH was confirmed by cranial sonography. Prior to extubation, T infants received 6 mg/kg theophylline loading dose IV or PO and then a maintenance dose 2 mg/kg q 12h for 5 doses. Control infants received equal volumes of normal saline. No significant differences existed between groups for birthweight, GA, duration of ventilation, and peak FiO2. Nine of 14 T infants and only 1 of 11 P infants were successfully extubated for at least 5 days (p=0.01). Of 5 T infant failures, 2 had congestive heart failure with patent ductus arteriosus and 3 had severe apnea. Of 10 P infant failures, 8 had recurrent apnea and 2 failed to wean from the respirator during the study period. Seven of 9 P infants were later successfully extubated with theophylline. We conclude that theophylline therapy prior to extubation of infants < 1250 gms is effective in preventing post-extubation respiratory failure.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Viscardi, R., Faix, R., Grasela, T. et al. 1554 efficacy of theophylline for prevention of post-extubation respiratory failure in INFANTS LESS THAN 1250 GRAMS. Pediatr Res 19, 369 (1985). https://doi.org/10.1203/00006450-198504000-01578
Issue Date:
DOI: https://doi.org/10.1203/00006450-198504000-01578